The proband A2 carrying a novel LMNA mutation presents both LGMD phenotype (which can be caused either by LMNA or CAPN3 mutation) and cardiomyopathy (not characteristic for LGMDR1). This evidence concerns the gene CAPN3 and cardiomyopathy.